Drugs · acquisition-cost intelligence
Olanzapine Intramuscular
Olanzapine· ingredient olanzapine· OLANZAPINE 10 mg/1; OLANZAPINE 10 mg/2mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$21.88
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 5 weeks.
2025-09-172026-05-20
Same-ingredient options by acquisition cost
Other olanzapine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Olanzapine | $0.09035 | −$21.79 |
| Olanzapine | $0.10950 | −$21.77 |
| Olanzapine | $0.14333 | −$21.73 |
| olanzapine | $0.52536 | −$21.35 |
| Zyprexa | $33.26 | +$11.38 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 4
Prior auth 16% · Step therapy 0% · Quantity limit 72% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.